NDAINJECTIONINJECTABLE
Approved
Jul 1954
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
6
Data completeness
6/8 — Strong
DELESTROGEN (estradiol valerate) by Pfizer is clinical pharmacology endogenous estrogens are largely responsible for the development and maintenance of the female reproductive system and secondary sexual characteristics. Approved for metrorrhagia, contraception, osteoporosis and 1 more indications. First approved in 1954.
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
DELESTROGEN (estradiol valerate) is a long-acting injectable estrogen agonist approved in 1954 for hormone replacement and contraceptive indications. It works by binding to estrogen receptors to modulate gonadotropin secretion and maintain reproductive function. The drug is indicated for metrorrhagia, contraception, osteoporosis, dysmenorrhea, infertility, and ovulation inhibition.
$0.132MPart D
LOE ApproachingDeclining
Product approaching loss of exclusivity with minimal Part D volume signals contraction phase and limited team expansion opportunities.
Mechanism of Action
CLINICAL PHARMACOLOGY Endogenous estrogens are largely responsible for the development and maintenance of the female reproductive system and secondary sexual characteristics. Although circulating estrogens exist in a dynamic equilibrium of metabolic interconversions, estradiol is the principal…
Worked on DELESTROGEN at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.